| Literature DB >> 29300743 |
Laura Alejandra Rico-Uribe1,2,3, Francisco Félix Caballero1,2,3, Natalia Martín-María1,2,3, María Cabello1,2,3, José Luis Ayuso-Mateos1,2,3, Marta Miret1,2,3.
Abstract
INTRODUCTION: Loneliness has social and health implications. The aim of this article is to evaluate the association of loneliness with all-cause mortality.Entities:
Mesh:
Year: 2018 PMID: 29300743 PMCID: PMC5754055 DOI: 10.1371/journal.pone.0190033
Source DB: PubMed Journal: PLoS One ISSN: 1932-6203 Impact factor: 3.240
Fig 1Preferred Reporting Items for Systematic Reviews (PRISMA) flow diagram.
Overview of studies included in the systematic review.
| STUDIES INCLUDED IN THE META-ANALYSES | |||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Code | First author | Year | Nation | Cohort | Follow-up | Sample age | Covariates | Mortality | Loneliness Instrument | Results | Effect Size HR (95%CI) | General or Clinical/ institutionalized | |
| 2 | Drageset [ | 2013 | Norway | 164 f | 5 Y | >65 (years) | Sx, Ag, Edu, MS, LS, CO, SI, RW, Nu, GDS. | Cancer | Social Provisions Scale (16-items) | ± | 0.96 (0.90, 1.06) | CL | |
| 3 | Eaker [ | 1992 | USA | 749 f | 20 Y | 45–64 (years) | Sx, Ag, S, HS, Di, BMI | Cardiovascular disease | Are you lonely during the day? (1-item) | + | 4 (1.8, 9.2) | G | |
| 4 | Ellwardt [ | 2016 | Netherlands | 1498 f | 20 Y | 55–85 | Sx, Ag, De, CoD, ADL, An, Hs | All-cause | De Jong Gierveld Loneliness Scale (11-items) | ± | 1.02 (0.99. 1.06) | G | |
| 6 | Grand [ | 1990 | France | 355 f | 4Y | +60 (years) | Ag | All-cause | Do you often feel lonely? (1-item) | ± | 1.42 (0.81, 2.50) | G | |
| 7 | Herlitz [ | 1998 | Sweden | 229 f | 5Y | 32–86 (years) | Ag, LV, S, CHF, Di, RD, PCD, IC. | Cardiovascular disease | "I feel lonely" (1-item from The Nottingham Health Profile) | + | 1.78 (1.17, 2,71) | CL | |
| 9a | Holwerda [ | 2012 | Netherlands | 1509 m | 10 Y | 65–84 (years) | Ag, Edu, SIs, HD, Di, CD, Ca, ReD, Ar, Ep, Pa, De, CoD, ADL. | All-cause | Do you feel lonely? (1-item) | + | 1.71 (1.41, 2,07) | G | |
| 9b | Holwerda [ | 2012 | Netherlands | 2495 f | 10 Y | 65–84 (years) | Ag, Edu, SIs, HD, Di, CD, Ca, ReD, Ar, Ep, Pa, De, CoD, ADL. | All-cause | Do you feel lonely? (1-item) | + | 1.28 (1.12, 1.46) | G | |
| 11 | Julsing [ | 2016 | Netherlands | 719 m | 25 Y | 64–85 (years) | Ag, Edu, S, PM, Al, BMI, CrD, DIOP, HCarD, FHSt, Chol, BPre, AnM, TDLo | All-cause | De Jong Gierveld Loneliness Scale (11-items) | ± | 1.40 (0.85, 2.31) | G | |
| 12a | Jylhä [ | 1989 | Finland | 472 m | 6,5 Y | 60–89 (years) | Ag, PH, FA, DD. | All-cause | Do you feel lonely? (1-item) | ± | 1.02 (0.75, 1.40) | G | |
| 12b | Jylhä [ | 1989 | Finland | 464 f | 6,5 Y | 60–89 (years) | Ag, PH, FA, DD. | All-cause | Do you feel lonely? (1-item) | ± | 1.17 (0.79, 1.74) | G | |
| 13 | Levy [ | 2005 | USA | 306 f | 23 Y | 50–78 (years) | Sx, Ag, MS, SRH, FH, SES. | Other cause | How often do you feel lonely? (1-item from Philadelphia Geriatric Center Morale Scale) | ± | 0.28 (0.08, 1.04) | G | |
| 15 | Luo [ | 2012 | USA | 1253 f | 6 Y | +50 (years) | Sx, Ag, Edu, MS, RFLN, SRH, Sl, PE, S, De, FL, RE, HA, HI. | All-cause | UCLA Loneliness Scale (3-items) | ± | 1.07 (0.99, 1.17) | G | |
| 17 | Maier [ | 1999 | Germany | 256 f | 7 Y | 70–103 (years) | Not controlled by covariates | All-cause | UCLA Loneliness Scale (4-items) | + | 1.28 (1.14, 1.44) | G | |
| 18a | Meller [ | 2004 | Germany | 82 m | 5 Y | +85 (years) | Sx, Ag, De, Cr, Ho, Ti, An, LI, RA, CRA. | All-cause | Geriatric Mental State (51-items) | + | 1.67 (0.71, 3.87) | G | |
| 18b | Meller [ | 2004 | Germany | 276 f | 5 Y | +85 (years) | Sx, Ag, De, Cr, Ho, Ti, An, LI, RA, CRA. | All-cause | Geriatric Mental State (51-items) | + | 1.79 (1.03, 3.09) | G | |
| 21a | Olsen [ | 1991 | Denmark | 715 m | 16 Y | 70–100 (years) | Ag, SAH, TLH, NoH5Y, SAHC, SAMH, PM, NEH, MPA, NEEVS. | Cardiovascular disease | Do you feel lonely? (1-item) | + | 1.70 (1.03, 2.81) | G | |
| 21b | Olsen [ | 1991 | Denmark | 1037 f | 16 Y | 70–100 (years) | Ag, SAH, TLH, NoH5Y, SAHC, SAMH, PM, NEH, MPA, NEEVS. | Cardiovascular disease | Do you feel lonely? (1-item) | ± | 1.09 (0.79, 1.49) | G | |
| 23 | Penninx [ | 1997 | Netherlands | 1452 f | 2,4 Y | 55–85 (years) | Sx, Ag, Edu, SS, PCR, SD, PL, SRH, Al, and S. | All-cause | De Jong Gierveld Loneliness Scale (11-items) | + | 1.06 (1.00, 1.12) | G | |
| 24 | Perissinotto [ | 2012 | USA | 953 f | 6 Y | +60 (years) | Sx, Ag, Edu, RE, NWAB, Wo, LA, CO, S, Al, BMI, PE, HVP, De, ADL, UET, PM, Cl, In. | All-cause | UCLA Loneliness Scale (3-items) | + | 1.45 (1.11, 1.88) | G | |
| 25 | Pitkala [ | 2004 | Finland | 354 f | 10 Y | 75, 80, 85 (years) | Sx, Ag, HS. | All-cause | Do you suffer from loneliness? (1-item) | ± | 1.16 (0.99, 1.39) | G | |
| 27 | Shiovitz-Ezra [ | 2010 | USA | 4486 f | 4 Y | +50 (years) | Sx, Ag, Edu, HS, FL, De. | All-cause | Felt lonely much of the time over the past week (1-item from Center for Epidemiologic Studies Depression Scale) | + | 1.83 (1.71, 1.87) | G | |
| 28 | Stek [ | 2005 | Germany | 305 f | 5Y | 85 (years) | Sx, Ag, De, Edu, MS, Ins, S, Al, CrD. | All-cause | Loneliness Scale of Tijhuis et al. (11-items) | ± | 1.30 (0.80, 1.90) | G | |
| 29 | Steptoe [ | 2013 | England | 3547 f | 7.25 Y | +50 (years) | Sx, Ag, Edu, MS, RE, LSI, MI, Ca, Di, CHD, CLD, Ar, St, De, CES-D, We. | All-cause | UCLA Loneliness Scale (3-items) | ± | 0.92 (0.78, 1.09) | G | |
| 30a | Stessman [ | 2014 | Israel | 145 f | 20 Y | 70–78 (years) | Sx, Edu, MS, PE, CP, Hy, HD, Di. | All-cause | How often they felt lonely? (1-item) | ± | 1.06 (0.54, 2.10) | G | |
| 30b | Stessman [ | 2014 | Israel | 233 f | 20 Y | 78–85 (years) | Sx, Edu, MS, PE, CP, Hy, HD, Di. | All-cause | How often they felt lonely? (1-item) | ± | 1.10 (0.69, 1.77) | G | |
| 30c | Stessman [ | 2014 | Israel | 351 f | 20 Y | 85–90 (years) | Sx, Edu, MS, PE, CP, Hy, HD, Di. | All-cause | How often they felt lonely? (1-item) | ± | 0.84 (0.56, 1.27) | G | |
| 32 | Tilvis [ | 2011 | Finland | 2556 f | 4.75 Y | +74 (years) | Sx, Ag, SRH. | All-cause | Do you suffer from loneliness? (1-item) | + | 1.17 (1.02, 1.33) | G | |
| 33a | Tilvis [ | 2012 | Finland | 1187 m | 7 Y | +75 (years) | Ag, SRH, FS, DH. | All-cause | Do you suffer from loneliness? (1-item) | ± | 1.17 (0.97, 1.41) | G | |
| 33b | Tilvis [ | 2012 | Finland | 2671 f | 7 Y | +75 (years) | Ag, SRH, FS, DH. | All-cause | Do you suffer from loneliness? (1-item) | ± | 1.02 (0.89, 1.17) | G | |
| 34 | Tilvis [ | 2012 | Finland | 1678 f | 4.75 Y | +75 (years) | Sx, Ag, SWL, FN, PF, ZL, NFD. | All-cause | Do you suffer from loneliness? (1-item) | ± | 1.18 (0.99, 1.42) | G | |
| 35 | Zhen [ | 2015 | China | 2164 f | 3 Y | +65 (years) | Sx, Ag, Edu, MS, S, RE, UR, In, PMC | All-cause | Sense of loneliness (1-item) | + | 1.18 (1.08, 1.25) | G | |
| 1 | Cuijpers [ | 2001 | Netherlands | 333 f | 1 Y | 84.5 (mean) | Sx, Ag, YH. | All-cause | De Jong Gierveld Loneliness Scale (12-items) | ± | CL | ||
| 5 | Giraldi [ | 1997 | Italy | 95 f | 6Y | -70 (years) | Not controlled by covariates | Cancer | UCLA Loneliness Scale (20-items) | ± | CL | ||
| 8 | Holt-Lunstad [ | 2015 | Meta-analytic review (studies included in this meta-analysis were considered as separate in our meta-analysis) | ||||||||||
| 10a | Iecovich [ | 2011 | Israel | 109 m | 18 Y | 70–88 (years) | MS, NoC, FMC, NoH, SRH, CO, FS, ES. | All-cause | Do you feel lonely? (1-item) | DNA | DNA | G | |
| 10b | Iecovich [ | 2011 | Israel | 115 f | 18 Y | 70–88 (years) | MS, NoC, FMC, NoH, SRH, CO, FS, ES. | All-cause | Do you feel lonely? (1-item) | DNA | DNA | G | |
| 14 | Ljungquist [ | 1996 | Sweden | 1062 m/f | 16 Y | +67 (years) | Not controlled by covariates | All-cause | Loneliness Index (2-items) | ± | DNA | G | |
| 16 | Luo [ | 2014 | China | 7444 f | 10 Y | +65 (years) | Sx, Ag, Edu, MS, NoC, LN, UR. | All-cause | How often the respondent feels lonely and isolated? (1-item) | + | DNA | G | |
| 19 | Miller [ | 1997 | USA | 205 m | 3 Y | 37 (mean) | HS, CD4 | Other cause AIDS-related mortality | UCLA Loneliness Scale (20-items) | ± | DNA | CL | |
| 20 | Newall [ | 2013 | Canada | 142 f | 35 Y | 77–96 (years) | Sx, Ag, MS, HS, Hap, IS. | All-cause | De Jong Gierveld Loneliness Scale (11-items) | + | G | ||
| 22 | Patterson [ | 2010 | USA | 3679 f | 34 Y | +21 (years) | Sx, Ag, Edu, MS, NoFR, PE, S, Sl, De, RE, In. | Cardiovascular disease | How often they feel "very lonely or remote from other people"? (1-item) | ± | G | ||
| 26 | Shahtahmasebi [ | 1992 | England | 534 m/f | 8 Y | +65 (years) | Ag | All-cause | Self-assessed loneliness (1-item) and loneliness measure (8-items) | ± | G | ||
| 31 | Sugisawa [ | 1994 | Japan | 1197 f | 3 Y | +60 (years) | Sx, Ag, Edu, MS, SC, SP, SS, SRH, CrD, FL, Al, S. | All-cause | Sense of loneliness (1-item) | DNA | DNA | G | |
Sample: Y = year(s); m = males; f = females; m/f = overall sample, data not available by gender.
Covariates: Sx (Sex); Ag (Age); Edu (Education); MS (Marital Status); LS (length of stay in nursing home); CO (comorbidity); SI (social integration); RW (reassurance of worth); Nu (nurturance); GDS (Geriatric Depression Scale); LV (left ventricular ejection fraction); S (Smoking); CHF (congestive heart failure); Di (diabetes); RD (renal dysfunction); PCD (previous cerebrovascular disease); IC (intermittent claudication); SIs (social isolation); HD (heart disease); CD (cerebrovascular disease); Ca (cancer); ReD (respiratory disease); Ar (arthritis); Ep (epilepsy); Pa (Parkinson); De (depression); CoD (cognitive decline); ADL (Activities Daily Life); NoC (number of children); FMC (frequency of meeting with children); NoH (number of people living in the same household); SRH (self-rated health); FS (functional status); SES (economic status); PH (perceived health); FA (functional ability); DD (disabling disease); FH (functional health); RFLN (relatives and friends living nearby); Sl (sleep); PE (physical exercise); FL (functional limitations); RE (race/ethnicity); HA (household assets); HI (household income); LN (living in nursing home); UR (urban/rural); Cr (crying); Ho (hopelessness); Ti (tiredness); An (anxiety); LI (loss of initiative); RA (repetition of acts); CRA (compulsive repetition of acts); Ne (neuroticism); PNP (proatrial natriuretic peptide); NYHAC (New York Heart Association Classification); HS (health status); Hap (happiness); IS (income satisfaction); SAH (self-assessment of health); TLH (time since last hospitalization); NoH5Y (number of hospitalizations over past 5 years); SAHC (self-assessment of health compared with others); SAMH (self-assessment of mental health); PM (physical mobility); NEH (nurse evaluation of health); MPA (mental and physical activity); NEEVS (nurse evaluation of expected vital status next year); NoFR (number of friends and relatives); In (income); SS (social support); PCR (personal coping resources); SD (specific diseases); PL (physical limitations); Al (alcohol use); NWAB (net worth of assets and debts); Wo (working status); LA (living arrangement); BMI (body mass index); HVP (hearing and vision problems); UET (upper extremities tasks); Cl (climbing); Ins (institutionalized); CrD (presence of chronic disease); LSI (long-standing illness); MI (mobility impairment); CHD (coronary heart disease); CLD (chronic lung disease); St (stroke); CES-D (Centre for Epidemiologic Studies Depression Scale); We (wealth); CP (chronic pain); Hy (hypertension); SC (social contacts); SP (social participation); SWL (satisfied with life); FN (feeling needed); PF (plans for future); ZL (zest for life); NFD (not feeling depressive); DH (daily help); RC (residential care); GOD (goes outdoors daily); CD4 (CD4 levels); PMC (covered by public medical service); DIOP (dispositional optimism); FHSt (family history of stroke); HCarD (history of cardiovascular disease); Chol (cholesterol); BPre (blood pressure); AnM (use of antihypertensive medication); TDLo (time-dependent loneliness).
General or Clinical/Institutionalized: G = general population; CL = clinical/institutionalized population; G/CL = both.
Results:— = protective (significant); ± = null (not significant); + = harmful (significant).
Effect Size: HR = hazard ratio; RR = risk ratio; 95% CI = 95% Confidence Interval;
* = effect size reported in odds ratio.
DNA: Data not available
Note: The articles that reported different effect sizes by gender or by age group were considered as different studies.
Characteristics of the studies included in the general meta-analysis.
| Characteristics | n = 31 |
|---|---|
| Both | 19 (61.29) |
| Males | 6 (19.35) |
| Females | 6 (19.35) |
| Both | 39011 (2053.21 ± 2116.74) |
| Males | 4684 (780.67 ± 507.37) |
| Females | 7692 (1282 ± 1041.73) |
| 12 (48.00) | |
| All-cause mortality | 25 (80.65) |
| Cardiovascular mortality | 4 (12.90) |
| Cancer mortality | 1 (3.23) |
| Respiratory mortality | 1 (3.23) |
| Studies that used a single item instrument | 20 (64.52) |
| Studies that used instruments with several items | 11 (35.48) |
| Protective (significant) | 0 |
| Null (not significant) | 18 (58.06) |
| Harmful (significant) | 13 (41.94) |
SE: Standard error; ≥10Y: Longer than ten years.
Quality evaluation of the articles included in the meta-analysis.
| Article | Bias due to confounding | Bias in selection of participants | Bias in measurement of mortality | Bias in measurement of loneliness | Bias in selection of the results | OVERALL |
|---|---|---|---|---|---|---|
| Drageset [ | Moderate risk | Moderate risk | Low risk | Low risk | Low risk | |
| Eaker [ | Moderate risk | Moderate risk | Serious risk | Moderate risk | Low risk | |
| Ellwardt [ | Moderate risk | Low risk | Low risk | Low risk | Low risk | |
| Grand [ | Serious risk | Moderate risk | Serious risk | Low risk | Low risk | |
| Herlitz [ | Serious risk | Moderate risk | Serious risk | Low risk | Low risk | |
| Holwerda [ | Moderate risk | Low risk | Low risk | Low risk | Low risk | |
| Julsing [ | Moderate risk | Low risk | Low risk | Low risk | Low risk | |
| Jylha [ | Serious risk | Low risk | Low risk | Low risk | Moderate risk | |
| Levy [ | Moderate risk | Moderate risk | Low risk | Low risk | Low risk | |
| Luo [ | Low risk | Low risk | Low risk | Low risk | Low risk | |
| Maier [ | Serious risk | Low risk | Low risk | Low risk | Low risk | |
| Meller [ | Serious risk | Low risk | Low risk | Low risk | Low risk | |
| Olsen [ | Moderate risk | Low risk | Low risk | Low risk | Moderate risk | |
| Penninx [ | Moderate risk | Low risk | Low risk | Low risk | Low risk | |
| Perissinotto [ | Low risk | Low risk | Low risk | Low risk | Low risk | |
| Pitkala [ | Serious risk | Low risk | Serious risk | Moderate risk | Low risk | |
| Shiovitz-Ezra [ | Moderate risk | Low risk | Low risk | Low risk | Low risk | |
| Stek [ | Low risk | Low risk | Serious risk | Low risk | Low risk | |
| Steptoe [ | Moderate risk | Low risk | Low risk | Low risk | Low risk | |
| Stessman [ | Moderate risk | Low risk | Low risk | Low risk | Low risk | |
| Tilvis [ | Serious risk | Low risk | Low risk | Moderate risk | Low risk | |
| Tilvis [ | Serious risk | Low risk | Low risk | Moderate risk | Low risk | |
| Tilvis [ | Serious risk | Low risk | Low risk | Moderate risk | Low risk | |
| Zhen [ | Moderate risk | Low risk | Serious risk | Moderate risk | Low risk |
Fig 2Forest plot of the studies included in the meta-analysis.
Note: Forest plot displaying an inverse-variance weighted random-effect meta-analysis. The codes of this figure correspond to the codes of Table 1.
Fig 3Forest plot of the studies included in the meta-analysis by gender.
Note: Forest plot displaying an inverse-variance weighted random-effect meta-analysis. The codes of this figure correspond to the codes of Table 1.
Fig 4Forest plot of the studies included according to the risk of bias.
Note: Forest plot displaying an inverse-variance weighted random-effect meta-analysis. The codes of this figure correspond to the codes of Table 1.
Fig 5Funnel plot depicting the relationship between effect size and standard error of effect for the studies in the meta-analysis.